|
US6358960B1
(en)
|
1998-02-17 |
2002-03-19 |
Ono Pharmaceutical Co., Ltd. |
Amidino derivatives and drugs containing the same as the active ingredient
|
|
US20030134853A1
(en)
*
|
2001-09-26 |
2003-07-17 |
Priestley Eldon Scott |
Compounds useful for treating hepatitis C virus
|
|
EP1533294A4
(en)
|
2002-05-28 |
2007-07-04 |
Ono Pharmaceutical Co |
BETA-ALANINE DERIVATIVE AND USE THEREOF
|
|
TW200408393A
(en)
|
2002-10-03 |
2004-06-01 |
Ono Pharmaceutical Co |
Antagonist of lysophosphatidine acid receptor
|
|
JP4766384B2
(ja)
|
2003-12-19 |
2011-09-07 |
小野薬品工業株式会社 |
リゾホスファチジン酸受容体拮抗作用を有する化合物およびその用途
|
|
RU2007109778A
(ru)
|
2004-08-17 |
2008-09-27 |
Галдерма Ресерч Энд Девелопмент, С.Н.С. (Fr) |
Новые биароматические соединения, которые активируют рецепторы типа ppar, и их применение в косметических и фармацевтических композициях
|
|
FR2874379B1
(fr)
|
2004-08-17 |
2006-10-27 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
WO2007019397A2
(en)
|
2005-08-05 |
2007-02-15 |
Genelabs Technologies, Inc. |
6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus
|
|
GB2466121B
(en)
|
2008-12-15 |
2010-12-08 |
Amira Pharmaceuticals Inc |
Antagonists of lysophosphatidic acid receptors
|
|
GB2474748B
(en)
|
2009-10-01 |
2011-10-12 |
Amira Pharmaceuticals Inc |
Polycyclic compounds as lysophosphatidic acid receptor antagonists
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
|
CN103347510B
(zh)
|
2010-12-07 |
2015-11-25 |
艾米拉医药股份有限公司 |
溶血磷脂酸受体拮抗剂及其在治疗纤维化中的用途
|
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
|
US20130122297A1
(en)
|
2011-10-24 |
2013-05-16 |
Northwestern University |
Molecular gauge blocks for building on the nanoscale
|
|
WO2013070879A1
(en)
|
2011-11-10 |
2013-05-16 |
Bristol-Myers Squibb Company |
Methods for treating spinal cord injury with lpa receptor antagonists
|
|
HK1206342A1
(en)
|
2012-06-20 |
2016-01-08 |
霍夫曼-拉罗奇有限公司 |
N-alkyltriazole compounds as lpar antagonists
|
|
SG11201507459YA
(en)
|
2013-03-15 |
2015-10-29 |
Epigen Biosciences Inc |
Heterocyclic compounds useful in the treatment of disease
|
|
JP6322704B2
(ja)
|
2013-06-27 |
2018-05-09 |
エルジー・ケム・リミテッド |
Ｇｐｒ１２０アゴニストとしてのビアリール誘導体
|
|
US10099981B2
(en)
|
2015-03-31 |
2018-10-16 |
University Of Georgia Research Foundation, Inc. |
Methods for meta-arylation of aromatic alcohols
|
|
MX387736B
(es)
|
2015-09-04 |
2025-03-18 |
Hoffmann La Roche |
Derivados de fenoximetilo.
|
|
AR108838A1
(es)
|
2016-06-21 |
2018-10-03 |
Bristol Myers Squibb Co |
Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
|
|
WO2019041340A1
(en)
|
2017-09-04 |
2019-03-07 |
Eli Lilly And Company |
LYSOPHOSPHATIDE ACID RECEPTOR 1 RECEPTOR INHIBITORS (LPAR1)
|
|
ES2925626T3
(es)
|
2017-12-19 |
2022-10-19 |
Bristol Myers Squibb Co |
Acidos isoxazol-O-carbamoilciclohexílicos como antagonistas de LPA
|
|
KR102725744B1
(ko)
|
2017-12-19 |
2024-11-01 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헥실 산 피라졸 아진
|
|
US11319309B2
(en)
|
2017-12-19 |
2022-05-03 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azines as LPA antagonists
|
|
KR20200100713A
(ko)
|
2017-12-19 |
2020-08-26 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헥실 산 트리아졸 아졸
|
|
WO2019126087A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azoles as lpa antagonists
|
|
CN112041029B
(zh)
|
2017-12-19 |
2025-01-24 |
百时美施贵宝公司 |
作为lpa拮抗剂的环己基酸吡唑唑类
|
|
ES2943661T3
(es)
|
2017-12-19 |
2023-06-15 |
Bristol Myers Squibb Co |
Acidos carbamoil ciclohexílicos pirazol-O-ligados como antagonistas de LPA
|
|
SG11202005701VA
(en)
|
2017-12-19 |
2020-07-29 |
Bristol Myers Squibb Co |
Pyrazole n-linked carbamoyl cyclohexyl acids as lpa antagonists
|
|
WO2019126093A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Cyclohexyl acid triazole azines as lpa antagonists
|
|
WO2019126099A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Isoxazole n-linked carbamoyl cyclohexyl acids as lpa antagonists
|
|
CA3046894A1
(en)
*
|
2018-06-18 |
2019-12-18 |
Epigen Biosciences, Inc. |
Heterocyclic compounds useful in the treatment of disease
|
|
KR102788997B1
(ko)
|
2018-09-18 |
2025-03-28 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 옥사비시클로 산
|
|
US20220041572A1
(en)
|
2018-09-18 |
2022-02-10 |
Bristol-Myers Squibb Company |
Cycloheptyl acids as lpa antagonists
|
|
KR102950123B1
(ko)
|
2018-09-18 |
2026-04-08 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로펜틸 산
|
|
CN111434653A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
三氮唑类化合物及其制备方法与用途
|
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
|
ES3054967T3
(en)
|
2019-06-18 |
2026-02-09 |
Bristol Myers Squibb Co |
Triazole carboxylic acids as lpa antagonists
|
|
KR102791678B1
(ko)
|
2019-06-18 |
2025-04-04 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로부틸 카르복실산
|
|
EP3986552B1
(en)
|
2019-06-18 |
2024-09-18 |
Bristol-Myers Squibb Company |
Isoxazole carboxylic acids as lpa antagonists
|
|
CN114206832B
(zh)
|
2019-07-30 |
2025-04-04 |
大正制药株式会社 |
拮抗lpa1受体的脲化合物
|
|
EP4073073B1
(en)
|
2019-12-12 |
2023-12-06 |
Chiesi Farmaceutici S.p.A. |
Thienopyrimidine derivatives as lpa receptor 2 inhibitors
|
|
US20230043672A1
(en)
|
2019-12-12 |
2023-02-09 |
Chiesi Farmaceutici S.P.A. |
Aromatic amido derivatives as lpa receptor 2 inhibitors
|
|
IL300525A
(en)
|
2020-08-11 |
2023-04-01 |
Viva Star Biosciences Ltd |
Triazole-pyridinyl-substituted azacyclohexyl acetic acid compounds as LPA receptor antagonists
|
|
WO2022083703A1
(en)
|
2020-10-22 |
2022-04-28 |
Lhotse Bio, Inc. |
Compounds and compositions for treating conditions associated with lpa receptor activity
|
|
WO2022100623A1
(zh)
|
2020-11-10 |
2022-05-19 |
武汉人福创新药物研发中心有限公司 |
氮取代杂环噻吩类化合物及其用途
|
|
CN114456157A
(zh)
|
2020-11-10 |
2022-05-10 |
武汉人福创新药物研发中心有限公司 |
氮取代氨基碳酸酯噻吩类化合物及其用途
|
|
CN114621135B
(zh)
|
2020-12-11 |
2024-01-30 |
上海拓界生物医药科技有限公司 |
一种lpa1小分子拮抗剂
|
|
EP4313956A1
(en)
|
2021-03-24 |
2024-02-07 |
Chiesi Farmaceutici S.p.A. |
8-cyclo-substituted quinazoline derivatives as lpa receptor 2 inhibitors
|
|
US20240317725A1
(en)
|
2021-07-20 |
2024-09-26 |
Tuojie Biotech (Shanghai) Co., Ltd. |
Lpa1 small molecule antagonist
|
|
JP2024540937A
(ja)
|
2021-10-21 |
2024-11-06 |
ローツェ・バイオ・インコーポレイテッド |
Ｌｐａ受容体活性に関連する状態を処置するための化合物および組成物
|
|
AR128613A1
(es)
*
|
2022-02-25 |
2024-05-29 |
Lhotse Bio Inc |
Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor de lpa
|
|
JP2025540714A
(ja)
|
2022-11-24 |
2025-12-16 |
ローツェ・バイオ・インコーポレイテッド |
Ｌｐａ受容体活性と関連する状態を処置するための化合物および組成物
|